LENZ Therapeutics (LENZ)

• Market cap: $204M
• 1 day: -1.66%
• 5 days: -2.98%
• 1 month: -5.51%
• 3 months: -44.46%
• 6 months: -60.96%
• Year to date: -59.25%
• 1 year: -77.38%
• 5 years: -94.97%
• 10 years: -94.97%
• Sector: Healthcare
• Industry: Biotechnology

About: LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Employees: 152